Plain-English translation of NCT07251868 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Breast Cancer research guide →This is a real-world study looking at how well sacituzumab govitecan works in people with breast cancer that has spread to the brain. Researchers will collect information from your medical records and regular hospital visits to understand whether this medication helps shrink brain tumors and what side effects patients experience when taking it in everyday clinical practice.
Breast cancer that spreads to the brain is very serious and hard to treat. Doctors need to know if this medication can help patients in real clinical settings, not just in controlled research environments, so they can better understand whether it's a good treatment option.
You likely qualify if…
You likely don't qualify if…
If you join, researchers will collect information from your medical records at participating hospitals and review your follow-up visits, which typically happen every 4 to 8 weeks. You'll have brain imaging scans to check how the tumors are responding, and doctors will monitor you for any side effects. You may also be contacted by phone or email so researchers can track how you're doing over time.
AI-generated summary from trial data · Aug 5, 2026 · Not medical advice
China